Back
MACOM Technology Solutions Holdings 10K Form
Buy
78
MTSI
MACOM Technology Solutions Holdings
Last Price:
121.94
Seasonality Move:
14.64%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive MTSI News And Ratings
See the #1 stock for the next 7 days that we like better than MTSI
MTSI Financial Statistics
Sales & Book Value
| Annual Sales: | $648.41M |
|---|---|
| Cash Flow: | $41.54M |
| Price / Cash Flow: | 66.67 |
| Annual Sales: | $14.98 |
| Price / Book: | 7.79 |
Profitability
| EPS (TTM): | 0.98000 |
|---|---|
| Net Income (TTM): | $71.9M |
| Gross Margin: | $385.8M |
| Return on Equity: | 7.17% |
| Return on Assets: | 4.37% |
MACOM Technology Solutions Holdings Earnings Forecast
Key MACOM Technology Solutions Holdings Financial Ratios
- The Gross Profit Margin over the past 15 years for MTSI is 59.50%.
- The Selling, General & Administrative Expenses for MTSI have been equal to 20.03% of Gross Profit Margin.
- The Research & Development expenses have been 22.91% of Revenue.
- The Interest Expense is 13.52% of Operating Income.
- The Net Earning history of MTSI is 14.12% of Total Revenues.
- Per Share Earnings over the last 15 years have been positive in 7 years.
MACOM Technology Solutions Holdings Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Semiconductors & Semiconductor Equipment |
| Sector: | Information Technology |
| Current Symbol: | MTSI |
| CUSIP: | 55405Y |
| Website: | macom.com |
Debt
| Debt-to-Equity Ratio: | 0.41 |
|---|---|
| Current Ratio: | 8.18 |
| Quick Ratio: | 6.09 |
Price-to-Earnings
| Trailing P/E Ratio: | 91.16 |
|---|---|
| Forward P/E Ratio: | 30.02 |
MTSI Technical Analysis vs Fundamental Analysis
Buy
78
MACOM Technology Solutions Holdings (MTSI)
is a Buy
Is MACOM Technology Solutions Holdings a Buy or a Sell?
-
MACOM Technology Solutions Holdings stock is rated a Buy
The current MACOM Technology Solutions Holdings [MTSI] share price is $116.69. The Score for MTSI is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.